Total Payments
$4,918
2024 Payments
$408.64
Companies
37
Transactions
370
Medicare Patients
434
Medicare Billing
$4,783
Payment Breakdown by Category
Food & Beverage$4,856 (98.7%)
Education$61.56 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,856 | 363 | 98.7% |
| Education | $61.56 | 7 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $539.48 | 46 | $0 (2024) |
| Novo Nordisk Inc | $527.27 | 58 | $0 (2023) |
| ABBVIE INC. | $454.82 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $414.44 | 22 | $0 (2023) |
| GlaxoSmithKline, LLC. | $389.22 | 27 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $344.34 | 28 | $0 (2023) |
| Lilly USA, LLC | $281.75 | 21 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $241.97 | 17 | $0 (2023) |
| Amgen Inc. | $166.27 | 12 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $142.23 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $408.64 | 29 | ABBVIE INC. ($234.39) |
| 2023 | $495.11 | 28 | Xeris Pharmaceuticals, Inc. ($113.18) |
| 2022 | $286.21 | 20 | ABBVIE INC. ($56.51) |
| 2021 | $110.71 | 4 | Biohaven Pharmaceuticals, Inc. ($64.77) |
| 2020 | $152.76 | 10 | AbbVie Inc. ($28.13) |
| 2019 | $1,174 | 92 | GlaxoSmithKline, LLC. ($195.53) |
| 2018 | $1,336 | 104 | Novo Nordisk Inc ($167.79) |
| 2017 | $954.67 | 83 | Boehringer Ingelheim Pharmaceuticals, Inc. ($207.62) |
All Payment Transactions
370 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.29 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: PAIN | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Inflammation | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Diabetes Care | ||||||
| 08/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Gastroenterology | ||||||
| 08/01/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Endocrinology | ||||||
| 07/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | ABBVIE INC. | SYNTHROID (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.46 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: RESPIRATORY | ||||||
| 05/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 98 | 139 | $3,186 | $1,024 |
| 2022 | 4 | 124 | 168 | $4,733 | $1,459 |
| 2021 | 3 | 112 | 161 | $3,723 | $1,208 |
| 2020 | 3 | 100 | 140 | $3,076 | $1,091 |
Total Patients
434
Total Services
608
Medicare Billing
$4,783
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 48 | 83 | $2,573 | $772.17 | 30.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 32 | 33 | $429.00 | $201.63 | 47.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 18 | 23 | $184.00 | $50.60 | 27.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 52 | 78 | $2,418 | $729.96 | 30.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 15 | 15 | $1,580 | $456.66 | 28.9% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 30 | 30 | $408.00 | $172.28 | 42.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 27 | 45 | $327.00 | $100.14 | 30.6% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 58 | 100 | $3,100 | $961.29 | 31.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 28 | 28 | $392.00 | $174.44 | 44.5% |
| 81003 | Automated urinalysis test | Office | 2021 | 26 | 33 | $231.00 | $72.13 | 31.2% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 53 | 89 | $2,523 | $858.49 | 34.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2020 | 30 | 30 | $420.00 | $186.06 | 44.3% |
| 81003 | Automated urinalysis test | Office | 2020 | 17 | 21 | $133.00 | $46.80 | 35.2% |
About Dr. Tabitha Culver, MD
Dr. Tabitha Culver, MD is a Family Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2009. The National Provider Identifier (NPI) number assigned to this provider is 1508090424.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tabitha Culver, MD has received a total of $4,918 in payments from pharmaceutical and medical device companies, with $408.64 received in 2024. These payments were reported across 370 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,856).
As a Medicare-enrolled provider, Culver has provided services to 434 Medicare beneficiaries, totaling 608 services with total Medicare billing of $4,783. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lexington, KY
- Active Since 05/06/2009
- Last Updated 12/03/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1508090424
Products in Payments
- CHANTIX (Drug) $263.22
- Tresiba (Drug) $248.49
- FARXIGA (Drug) $222.13
- XIFAXAN (Drug) $185.32
- VRAYLAR (Drug) $165.62
- LYRICA (Drug) $152.38
- TRELEGY ELLIPTA (Drug) $149.89
- ENTRESTO (Drug) $148.69
- ANORO (Drug) $128.98
- Aimovig (Biological) $122.99
- XARELTO (Drug) $116.01
- GVOKE HYPOPEN (Drug) $113.18
- Victoza (Drug) $112.04
- UBRELVY (Drug) $108.82
- NURTEC ODT (Drug) $106.22
- REXULTI (Drug) $104.63
- EMGALITY (Drug) $102.74
- QULIPTA (Drug) $97.09
- TRULICITY (Drug) $95.75
- MYDAYIS (Drug) $95.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lexington
Dr. Keith Stokes, Md, MD
Family Medicine — Payments: $550,575
Family Medicine $550,575
John Richard, Md, MD
Family Medicine — Payments: $438,915
Family Medicine $438,915
Dr. Susan Neil, Md, MD
Family Medicine — Payments: $23,499
Family Medicine $23,499
William Crigler, Md, MD
Family Medicine — Payments: $18,109
Family Medicine $18,109
Dr. Mark Weiser, Md, MD
Family Medicine — Payments: $12,183
Family Medicine $12,183
Dr. William Dacus, Md, MD
Family Medicine — Payments: $11,475
Family Medicine $11,475